First and Only Human Milk-Based Product for Infants with Gastroschisis
Achieving adequate growth and weight gain is critical for healthy development in critically ill infants requiring a corrective surgical procedure. Developed by Prolacta Bioscience®, Surgifort® is the first and only 100% human milk-based fortifier intended for term infants with gastroschisis who have undergone a corrective procedure.
Now, you have options
Health care professionals seeking a nutritional product clinically proven to support the growth and overall development of critically ill infants requiring surgery, need not look further.
Surgifort fortifier is a concentrated, pasteurized, liquid human milk-based product that contains calories, protein, fat, and carbohydrate derived from donated human milk, with added minerals. As part of an Exclusive Human Milk Diet (EHMD), Surgifort fortifier has been found to reduce the time to full feeds as well as improve weight gain velocity in babies recovering from gastroschisis repair (weight gain from the day Surgifort fortifier started until the day it was discontinued = 33.3 g/day).1
Learn More About Surgifort
Standardized quality and safety from start to finish
Surgifort® fortifier, follows the same quality and safety guidelines for human milk collection and use as Prolacta’s other products. From donor to recipient, the entire life cycle of Prolacta’s human milk–based nutritional products follows a standardized production process, including donor qualification; screening and blood testing; shipping; DNA matching; testing; storage and processing; pasteurization and manufacturing; and final product testing and quality review.
Hospitals choose Prolacta’s 100% human milk–based nutritional products knowing that they are receiving safe, standardized donor milk products processed under the strictest quality and safety guidelines to protect the health and well-being of their most fragile patients.